Prospects for new restorative and neuroprotective treatments in Parkinson's disease
Identifieur interne : 001220 ( Main/Exploration ); précédent : 001219; suivant : 001221Prospects for new restorative and neuroprotective treatments in Parkinson's disease
Auteurs : Stephen B. Dunnett [Royaume-Uni] ; Anders Bjrklund [Suède]Source :
- Nature [ 0028-0836 ] ; 1999-06-24.
Abstract
The degeneration of forebrain dopamine systems in Parkinson's disease has been an effective target for pharmaceutical research over the past four decades. However, although dopamine replacement may alleviate the symptoms of the disease, it does not halt the underlying neuronal degeneration. The past decade has seen major advances in identifying discrete genetic and molecular causes of parkinsonism and mapping the events involved in nigral cell death. This new understanding of the pathogenesis of the disease now offers novel prospects for therapy based on targeted neuroprotection of vulnerable neurons and effective strategies for their replacement.
Url:
DOI: 10.1038/399a032
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Prospects for new restorative and neuroprotective treatments in Parkinson's disease</title><author><name sortKey="Dunnett, Stephen B" sort="Dunnett, Stephen B" uniqKey="Dunnett S" first="Stephen B." last="Dunnett">Stephen B. Dunnett</name></author><author><name sortKey="Bjrklund, Anders" sort="Bjrklund, Anders" uniqKey="Bjrklund A" first="Anders" last="Bjrklund">Anders Bjrklund</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:C1A141390F9006FDCE54B5B66D7AA9ABD4E7655A</idno><date when="2006" year="2006">2006</date><idno type="doi">10.1038/399a032</idno><idno type="url">https://api.istex.fr/document/C1A141390F9006FDCE54B5B66D7AA9ABD4E7655A/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">000C28</idno><idno type="wicri:Area/Main/Curation">000A78</idno><idno type="wicri:Area/Main/Exploration">001220</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Prospects for new restorative and neuroprotective treatments in Parkinson's disease</title><author><name sortKey="Dunnett, Stephen B" sort="Dunnett, Stephen B" uniqKey="Dunnett S" first="Stephen B." last="Dunnett">Stephen B. Dunnett</name><affiliation wicri:level="4"><country xml:lang="fr" wicri:curation="lc">Royaume-Uni</country><wicri:regionArea>Stephen Dunnett is at the Centre for Brain Repair, University of Cambridge, Forvie Site, Robinson Way, Cambridge CB2 2PY</wicri:regionArea><orgName type="university">Université de Cambridge</orgName><placeName><settlement type="city">Cambridge</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Angleterre de l'Est</region></placeName></affiliation></author><author><name sortKey="Bjrklund, Anders" sort="Bjrklund, Anders" uniqKey="Bjrklund A" first="Anders" last="Bjrklund">Anders Bjrklund</name><affiliation wicri:level="1"><country xml:lang="fr">Suède</country><wicri:regionArea>Anders Bjrklund is at the Wallenberg Neuroscience Center, Lund University, Slvegatan 17, S-22362 Lund</wicri:regionArea><wicri:noRegion>S-22362 Lund</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Nature</title><idno type="ISSN">0028-0836</idno><idno type="eISSN">1476-4687</idno><imprint><publisher>Nature Publishing Group</publisher><date type="published" when="1999-06-24">1999-06-24</date><biblScope unit="volume">399</biblScope><biblScope unit="issue">Supplementary</biblScope><biblScope unit="page" from="A32">A32</biblScope><biblScope unit="page" to="A39">A39</biblScope></imprint><idno type="ISSN">0028-0836</idno></series><idno type="istex">C1A141390F9006FDCE54B5B66D7AA9ABD4E7655A</idno><idno type="DOI">10.1038/399a032</idno><idno type="ArticleID">399a032</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0028-0836</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="eng">The degeneration of forebrain dopamine systems in Parkinson's disease has been an effective target for pharmaceutical research over the past four decades. However, although dopamine replacement may alleviate the symptoms of the disease, it does not halt the underlying neuronal degeneration. The past decade has seen major advances in identifying discrete genetic and molecular causes of parkinsonism and mapping the events involved in nigral cell death. This new understanding of the pathogenesis of the disease now offers novel prospects for therapy based on targeted neuroprotection of vulnerable neurons and effective strategies for their replacement.</div></front></TEI><affiliations><list><country><li>Royaume-Uni</li><li>Suède</li></country><region><li>Angleterre</li><li>Angleterre de l'Est</li></region><settlement><li>Cambridge</li></settlement><orgName><li>Université de Cambridge</li></orgName></list><tree><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Dunnett, Stephen B" sort="Dunnett, Stephen B" uniqKey="Dunnett S" first="Stephen B." last="Dunnett">Stephen B. Dunnett</name></region></country><country name="Suède"><noRegion><name sortKey="Bjrklund, Anders" sort="Bjrklund, Anders" uniqKey="Bjrklund A" first="Anders" last="Bjrklund">Anders Bjrklund</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001220 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001220 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:C1A141390F9006FDCE54B5B66D7AA9ABD4E7655A
|texte= Prospects for new restorative and neuroprotective treatments in Parkinson's disease
}}
| This area was generated with Dilib version V0.6.23. |  |